论文部分内容阅读
目的探讨脑脊液置换术联合中药治疗原发性蛛网膜下腔出血的临床疗效。方法选取2013年3月—2016年3月宝鸡市中医医院收治的原发性蛛网膜下腔出血患者80例,根据治疗方法分为对照组和观察组,每组40例。对照组患者采用常规西药治疗,观察组患者行脑脊液置换术同时口服或鼻饲中药。比较两组患者临床疗效、再出血发生率及并发症发生率。结果观察组患者临床疗效优于对照组(P<0.05)。观察组患者再出血发生率和并发症发生率低于对照组(P<0.05)。结论脑脊液置换术联合中药治疗原发性蛛网膜下腔出血的临床疗效良好,可有效降低患者再出血和并发症发生率。
Objective To investigate the clinical efficacy of cerebrospinal fluid replacement combined with traditional Chinese medicine in the treatment of primary subarachnoid hemorrhage. Methods Eighty patients with primary subarachnoid hemorrhage admitted from March 2013 to March 2016 in Baoji Chinese Medicine Hospital were divided into control group and observation group according to the treatment method, 40 cases in each group. The control group of patients treated with conventional Western medicine, observation group patients undergoing cerebrospinal fluid replacement surgery while oral or nasogastric Chinese medicine. The clinical efficacy, the incidence of rebleeding and the incidence of complications were compared between the two groups. Results The clinical efficacy of the observation group was better than that of the control group (P <0.05). The incidence of rebleeding and complication in the observation group was lower than that in the control group (P <0.05). Conclusion Cerebrospinal fluid replacement combined with traditional Chinese medicine treatment of primary subarachnoid hemorrhage has a good clinical efficacy, which can effectively reduce the incidence of patients with rebleeding and complications.